$2.600
-0.151 (-5.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BLRX Prediction & Forecast by Similar Chart Analysis
Alphio's BLRX stock price prediction model matches the current BioLine RX Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.62 (+0.61%). The 1-week path is $2.60 (+0.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioLine RX Ltd Stock?
Currently, BioLine RX Ltd (BLRX) is not a strong buy due to its recent performance and financial instability. The stock price is at $2.60, with a 1-year change of -30.67%, indicating a significant decline over the past year. Additionally, the RSI is at 36.368, suggesting that the stock is nearing oversold territory but is not yet a clear buy signal. The forward P/E ratio is extremely high at 93.46, which raises concerns about valuation. The main risk is the company's negative net income, which was -$2.24 million in the last quarter, indicating ongoing financial struggles. Overall, while there are some positive indicators, such as a recent earnings beat and revenue growth, the financial instability and high valuation suggest that investors should hold off on buying until there are clearer signs of recovery.
BLRX stock price ended at $2.60 on Friday, after losing -5.80%
BioLine RX Ltd (BLRX) last closed at $2.6, losing -5.80%. These facts feed the 1-day and 1-week BLRX price prediction above.
Analyst Consensus
BioLine RX Ltd (BLRX): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
BioLine RX Ltd (BLRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BLRX, ranked by similarity.
Seasonality analysis for BLRX
Historically the probability of a positive August return for BLRX is 7.94%. January offers the highest probability of a positive month at 36.07%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BLRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.45 | $3.96 | $4.54 | +52.38% |
| Sep 2026 | $4.59 | $4.98 | $5.00 | +91.53% |
| Oct 2026 | $4.57 | $4.89 | $5.21 | +87.99% |
| Nov 2026 | $4.47 | $4.73 | $5.11 | +81.96% |
| Dec 2026 | $4.26 | $4.62 | $4.97 | +77.64% |
In 2026, BioLine RX Ltd (BLRX) is projected to range from $3.45 to $5.21.
BioLine RX Ltd 2026 monthly forecast
In Aug 2026, BioLine RX Ltd is projected to average $3.96, with a low of $3.45 and high of $4.54.
In Sep 2026, BioLine RX Ltd is projected to average $4.98, with a low of $4.59 and high of $5.00.
In Oct 2026, BioLine RX Ltd is projected to average $4.89, with a low of $4.57 and high of $5.21.
In Nov 2026, BioLine RX Ltd is projected to average $4.73, with a low of $4.47 and high of $5.11.
In Dec 2026, BioLine RX Ltd is projected to average $4.62, with a low of $4.26 and high of $4.97.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.